RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...
RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc.
Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...
The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...
The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...
A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
I am shocked to learn that the Idaho Senate is considering a bill that would outright ban mRNA vaccines in the state for 10 years. Banning mRNA vaccines would make the COVID vaccine unavailable to ...
As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...
The strangely adorable and resilient tardigrade, or water bear, just might hold the key to making cancer treatment a lot more ...
The world’s most resilient animal, the microscopic tardigrade, produces a radiation resisting protein that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback